Diagnostics investments and disease burden.
Saved in:
| Title: | Diagnostics investments and disease burden. |
|---|---|
| Authors: | Phillips KA; Center for Translational and Policy Research on Precision Medicine, Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA, USA., Horn DM; Center for Translational and Policy Research on Precision Medicine, Department of Clinical Pharmacy, University of California, San Francisco, CA, USA.; Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, CA, USA., Califf RM; Duke University School of Medicine, Durham, NC, USA. |
| Source: | Science (New York, N.Y.) [Science] 2026 Apr 09; Vol. 392 (6794), pp. 151-153. Date of Electronic Publication: 2026 Apr 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1095-9203 |
|---|---|
| DOI: | 10.1126/science.aec0173 |
